Current Neuro-Oncology
Volume
16 Number 12
31 December 2014
Home > Publications > Current Neuro-Oncology > Volume 16, Year 2014 > Number 12, 31 December
Di
Stefano AL, Labussiere M, Lombardi G, Eoli M, Bianchessi D,
Pasqualetti F, Farina P, Cuzzubbo S, Gallego-Perez-Larraya J,
Boisselier B, Ducray F, Cheneau C, Moglia A, Finocchiaro G, Marie
Y, Rahimian A, Hoang-Xuan K, Delattre JY, Mokhtari K, Sanson M.
VEGFA
SNP rs2010963 is associated with vascular toxicity in recurrent
glioblastomas and longer response to bevacizumab.
J
Neurooncol.
2014 Dec 7, 2015;121(3):499-504∟.
doi: 10.1007/s11060-014-1677-x∟.
PMID: 25488073∟.
Laboratory investigation. ˍ
Kim
HR, Kim SH, Lee JI, Seol HJ, Nam DH, Kim ST, Park K, Kim JH, Kong
DS.
Outcome
of radiosurgery for recurrent malignant gliomas: assessment of
treatment response using relative cerebral blood volume.
J
Neurooncol. 2014 Dec 9, 2015;121(2):311-8∟.
doi:
10.1007/s11060-014-1634-8∟.
PMID:
25488072∟.
Observational study. ˍ
Chheda
MG, Wen PY, Hochberg FH, Chi AS, Drappatz J, Eichler AF, Yang D,
Beroukhim R, Norden AD, Gerstner ER, Betensky RA, Batchelor TT.
Vandetanib
plus sirolimus in adults with recurrent glioblastoma: results of a
phase I and dose expansion cohort study.
J
Neurooncol.
2014 Dec 13, 2015;121(3):627-34∟.
doi:
10.1007/s11060-014-1680-2∟.
PMID:
25503302∟.
Interventional study. ˍ
Iwamoto
FM.
Comment:
Medical therapy for recurrent or progressive meningiomas remains
elusive.
Neurology.
2014 Dec 19, 2015;84(3):285∟.
doi: 10.1212/WNL.0000000000001170∟.
PMID: 25527267∟.
Comment. ˍ
Refers
to: Norden
AD, et al., Phase
II study of monthly pasireotide LAR (SOM230C) for recurrent or
progressive meningioma.
Neurology. 2014 Dec 19,
2015;84(3):280-6∟.
doi: 10.1212/WNL.0000000000001153∟.
PMID: 25527270∟.
Interventional study. ˍ
Norden
AD, Ligon KL, Hammond SN, Muzikansky A, Reardon DA, Kaley TJ,
Batchelor TT, Plotkin SR, Raizer JJ, Wong ET, Drappatz J, Lesser
GJ, Haidar S, Beroukhim R, Lee EQ, Doherty L, Lafrankie D, Gaffey
SC, Gerard M, Smith KH, McCluskey C, Phuphanich S, Wen PY.
Phase
II study of monthly pasireotide LAR (SOM230C) for recurrent or
progressive meningioma.
Neurology.
2014 Dec 19, 2015;84(3):280-6∟.
doi: 10.1212/WNL.0000000000001153∟.
PMID: 25527270∟.
Interventional study. ˍ
Burzynski
SR, Janicki TJ, Burzynski GS, Brookman S.
Preliminary
Findings on the Use of Targeted Therapy with Pazopanib and Other
Agents in Combination with Sodium Phenylbutyrate in the Treatment
of Glioblastoma Multiforme.
J
Cancer Ther. 2014 Dec 25,
2014;5(14):1423-1437.
doi:
10.4236/jct.2014.514144∟.
Interventional
study.
ˍ
Zhong
J, Ali AN, Voloschin AD, Liu Y, Curran WJ Jr, Crocker IR, Shu HG.
Bevacizumab-induced
hypertension is a predictive marker for improved outcomes in
patients with recurrent glioblastoma treated with
bevacizumab.
Cancer.
2014 Dec 29, 2015;121(9):1456-62∟.
doi: 10.1002/cncr.29234∟.
PMID: 25557543∟.
Observational study. ˍ